Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: StanChart, AstraZeneca lift FTSE 100 into green

Fri, 28th Jul 2023 08:52

(Alliance News) - Stock prices in London opened higher on Friday, boosted by a mostly strong set of company earnings, while investors weighed recent central bank decisions.

The FTSE 100 index opened up 21.41 points, 0.3%, at 7,714.17. The FTSE 250 was down 90.04 points, 0.5%, at 19,183.33, and the AIM All-Share was down 1.13 points, 0.2%, at 768.16.

The Cboe UK 100 was up 0.1%, the Cboe UK 250 was down 0.5% at 16,860.93, and the Cboe Small Companies was up 0.1% at 13,816.04.

In European equities on Friday, the CAC 40 in Paris was down 0.4%, while the DAX 40 in Frankfurt was down 0.1%. French equities failed to get a boost from a stronger-than-expected gross domestic product print, and returned some of their gains from Thursday.

The French economy saw a surprisingly robust performance in the second quarter of this year, growing by 0.5% from the first quarter, the statistics office announced.

The figure was well above the INSEE statistics office's own forecast of 0.1% growth for April to June and the expectations of analysts. It was also ahead of the 0.2% quarter growth seen in the first quarter.

Meanwhile, stocks in the FTSE 100 were outperforming their continental counterparts.

Standard Chartered was the top performer, up 5.4%.

The Asia-focused bank launched a new USD1 billion share buyback programme, as it reported a 20% rise in profit in the first half of 2023 and raised its guidance for the full year.

Pretax profit in the six months that ended June 30 was USD3.32 billion, up 20% from USD2.77 billion a year before. Operating income increased by 11% to USD9.13 billion from USD8.23 billion, and StanChart also benefitted from a reduced credit impairment of USD161 million, down from USD263 million a year before.

StanChart declared a 6 cents per share ordinary interim dividend, up 50% from a year before.

NatWest's interim results received a more muted reception, however, with its shares rising 0.3%.

Fresh from scandal, the bank touted its "robust balance sheet, with a high-quality deposit base, high levels of liquidity and a well-diversified loan book". In the first half of 2023, total income rose to GBP7.73 billion from GBP6.22 billion a year before, as net interest income came in at GBP5.73 billion from GBP4.33 billion. Operating pretax profit climbed to GBP3.59 billion from GBP2.62 billion. It declared an interim dividend of 5.5 pence and intends to begin a buyback of up to GBP500 million in the second half, in addition to the GBP1.3 billion buyback completed in the second quarter.

The results come amid the dramatic fallout in the row sparked by Nigel Farage over the closure of his Coutts bank account, which culminated in the resignation of NatWest CEO Alison Rose and the boss of Coutts, which is owned by the banking group.

"The bank is in extremely good shape in virtually all of its key metrics," noted interactive investor's Richard Hunter.

AstraZeneca rose 3.4% as it said pretax profit surged to GBP4.35 billion in the first half 2023, from just USD800 million a year before. Revenue rose edged up to USD22.30 billion from USD22.16 billion. The company reported significantly lower cost of sales, down 41% to USD3.87 billion from USD6.51 billion.

"Each of our non-Covid-19 therapy areas saw double-digit revenue growth, with eight medicines delivering more than USD1 billion of revenue in the first half, demonstrating the strength of our business," said CEO Pascal Soriot.

In the FTSE 250, Vanquis Banking plunged 25%.

The lender swung to a pretax loss of GBP14.5 million in the first half, from a profit of GBP46.9 million the year before. Total income slipped to GBP237.1 million from GBP240.3 million.

Sterling was quoted at USD1.2782 early Friday, down from USD1.2865 at the London equities close on Thursday. The euro traded at USD1.0963, lower than USD1.0996.

In Asia on Friday, the Nikkei 225 index in Tokyo closed down 0.4%, having fallen as low as 2.4%. The yen strengthened following a policy adjustment from Japan's central bank.

The Bank of Japan said it will allow "greater flexibility" in controlling bond yields, as it raised its full-year inflation forecast to 2.5% from its previous estimate of 1.8%.

It said it would continue to allow 10-year JGB yields to "fluctuate in the range of around plus and minus 0.5 percentage points from the target level, while it will conduct yield curve control with greater flexibility regarding the upper and lower bounds of the range as references, not as rigid limits," the central bank said in a statement. The bank also kept its short-term interest rate target unchanged at minus 0.1%.

Against the yen, the dollar was quoted at JPY139.10, down versus JPY141.07.

In China, the Shanghai Composite closed up 1.8%, while the Hang Seng index in Hong Kong was up 1.4%. The S&P/ASX 200 in Sydney closed down 0.7%.

In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average down 0.7%, the S&P 500 down 0.6% and the Nasdaq Composite down 0.6%.

Equities had earlier made a bright start after figures showed the US economy grew by more than expected in the second quarter of 2023, according to the first estimate from the US Bureau of Economic Analysis.

Quarter-on-quarter gross domestic product in the US increased 2.4% on an annualised basis in the second quarter of the year. In the first quarter, real GDP increased 2.0%, showing that the US economy has gathered some momentum.

Investors will have a keen eye on the US personal consumption expenditures reading at 1330 BST, which contains the latest core personal consumption expenditures deflator - the Federal Reserve's preferred metric of inflation.

Friday's economic calendar also has a German GDP reading at 0900 BST and an inflation reading from the eurozone's largest economy at 1300 BST.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.